Displaying 1 to 2 of 2 investments
Country Date Notes
Poseida Therapeutics Inc
United States 22 Apr 2019 Series C
Led the investment round. Active
Vedere Bio II
Acquisition
Initial investment. Round participant. Exited (Write-off)